Please wait a minute...
European Journal of Gynaecological Oncology  2018, Vol. 39 Issue (2): 310-313    DOI: 10.12892/ejgo3859.2018
Case Report Previous articles | Next articles
Recurrent endometriosis following tibolone hormone replacement therapy after mucinous ovarian carcinoma
B.D. de-la-Noval1, *(), M.D. Diestro Tejeda1, L. Yébenes2, I. Zapardiel1, A. Hernández Gutiérrez1, J. De-Santiago García1
1 Gynaecology Oncology Unit, Gynaecology and Obstetrics Department, Hospital Universitario La Paz, Madrid, Spain
2 Pathological Anatomy Department; Hospital Universitario La Paz, Madrid, Spain
Download:  PDF(293KB)  ( 73 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
The aim is to describe an atypical clinical case of endometriosis in a young patient with surgically induced menopause due to an ovarian mucinous carcinoma. Case Report: A 34-year old woman with deep endometriosis developed a large mass occupying the whole abdominal cavity, without ascites or carcinomatosis. A decisional laparoscopy and complete surgical staging were performed according to a FIGO Stage IA ovarian mucinous carcinoma. The patient required hormonal replacement therapy with tibolone. A year later, an endometriotic nodule appeared in the bladder, and two years after, endometriosis on the bowel and the vaginal vault without evidence of tumoral relapse also occurred. The patient was referred to the obesity unit and discontinued tibolone, with clinical and radiological stabilization. Conclusion. Tibolone should be used with caution in patients with a previous history of endometriosis and it is recommended to avoid hyperestrogenic situations in gynaecological malignancies in hormone-dependent diseases.
Key words:  Endometriosis      Epithelial ovarian cancer      Mucinous adenocarcinoma      Obesity      Tibolone     
Published:  10 April 2018     
*Corresponding Author(s):  B. DíAZ-DE-LA-NOVAL     E-mail:  begodelanoval@gmail.com

Cite this article: 

B.D. de-la-Noval, M.D. Diestro Tejeda, L. Yébenes, I. Zapardiel, A. Hernández Gutiérrez, J. De-Santiago García. Recurrent endometriosis following tibolone hormone replacement therapy after mucinous ovarian carcinoma. European Journal of Gynaecological Oncology, 2018, 39(2): 310-313.

URL: 

https://ejgo.imrpress.com/EN/10.12892/ejgo3859.2018     OR     https://ejgo.imrpress.com/EN/Y2018/V39/I2/310

[1] Diane E. Mahoney, Shariska Petersen, Lori Spoozak, Brenda M. Linares, Janet D. Pierce. The role of microbiota in epithelial ovarian cancer: a scoping review[J]. European Journal of Gynaecological Oncology, 2021, 42(5): 1006-1017.
[2] Ana Carolinne da Silva, Millena Prata Jammal, Renata Margarida Etchebehere, Eddie Fernando Candido Murta, Rosekeila Simões Nomelini. Association of cancer-associated fibroblasts and survival in malignant ovarian neoplasms[J]. European Journal of Gynaecological Oncology, 2021, 42(4): 782-787.
[3] Yuri Tachibana, Tsutomu Ida, Shunya Funazaki, Keijiro Sumori. Panniculus traction and Pfannenstiel incision for hysterectomy in a super obese patient with early-stage endometrial cancer[J]. European Journal of Gynaecological Oncology, 2021, 42(4): 808-810.
[4] Mehmet Sait Bakır, Özer Birge, Ceyda Karadag, Selen Doğan, Hasan Aykut Tuncer, Tayup Simsek. Clinicopathological risk factors and survival analysis of ovarian cancer with synchronous endometrial cancer diagnosed after surgery[J]. European Journal of Gynaecological Oncology, 2021, 42(3): 499-505.
[5] Meng-Hui Huang, Yun Han, Qing-Hua Xi, Yun-Feng Jin, Ying-Lei Liu, Yu-Wen Han, Hai-Li Kai, Qian Zhang, Yan-Li Zheng. Exploration on correlation of high DLX2 expression with poor prognosis and cellular proliferation in epithelial ovarian cancers[J]. European Journal of Gynaecological Oncology, 2021, 42(3): 521-529.
[6] Chun-Yu Zhang, Chun-Yan Chen, Hai-Xia Wen, Zi-Feng Song, Ping-Ping Hu. miR-182-5p enhances cisplatin resistance in epithelial ovarian cancer by downregulating GRB2[J]. European Journal of Gynaecological Oncology, 2021, 42(2): 353-359.
[7] Ece Gumusoglu, Tuba Gunel, Mohammad Kazem Hosseini, Nogayhan Seymen, Taylan Senol, Uğur Sezerman, Samet Topuz, Kılıç Aydınlı. The importance of dysregulated miRNAs on ovarian cysts and epithelial ovarian cancer[J]. European Journal of Gynaecological Oncology, 2021, 42(1): 66-72.
[8] Sefa Kurt, Selim Kandemir, Onur Yavuz, Meral Koyuncuoglu, Emine Cagnur Ulukus, Murat Celiloglu. Persistent tubal epithelium in ovaries after salpingectomy[J]. European Journal of Gynaecological Oncology, 2020, 41(6): 919-923.
[9] Yudi Mulyana Hidayat, Gatot Nyarumenteng Adhipurnawan Winarno, Maringan Diapari Lumban Tobing, Arieff Kustiandi, Kemala Isnainiasih Mantilidewi, Sofie Rifayani Krisnadi. The Role of Akt2 and CA-125 Serum Levels as Predictors for Successful Cytoreduction in Epithelial Ovarian Cancer Surgery[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 739-744.
[10] Lingyun Zhai, Lixin Zeng, Hongru Jiang, Wei Li. Effects of a cyclooxygenase-1-selective inhibitor in combination with taxol or cisplatin on cyclin D1, apoptosis, and vascular endothelial growth factor in a xenograft model of ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(5): 779-784.
[11] Gen-Hai Zhu, Kang Wang, Lan Hong, Xin-Hui Fu, Fu-Jin Liu, Hai-Yan Huang. Safety and efficacy of fertility-sparing surgery for an orthotopic xenograft model of epithelial ovarian cancer in nude mice[J]. European Journal of Gynaecological Oncology, 2020, 41(4): 609-616.
[12] Chenchen Zhu, Hanyuan Liu, Zhen Shen, Yanhu Xie, Tianjiao Zhang, Björn Nashan, Dabao Wu, Ying Zhou. Treatment and survival outcomes from epithelial ovarian cancer in women aged 65 years or older[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 415-421.
[13] Marcin Jedryka, Agnieszka Chrobak, Anna Chelmonska-Soyta, Daria Fijalkowska, Rafal Matkowski. Decreased expression of estrogen receptors alpha and beta in peripheral blood lymphocytes from the endometrial cancer patients and women with endometriosis[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 375-379.
[14] Emine Karabuk, Burak Karadag, Ceyda Karadag, M. Faruk Kose, M. Murat Naki, E. Nilufer Guler. The outcomes of fertility sparing surgery in epithelial ovarian cancer[J]. European Journal of Gynaecological Oncology, 2020, 41(3): 391-395.
[15] Can Fang, Yan Zhao, Kezhen Li, Danhui Weng, Peng Wu, Gang Chen, Ding Ma, Juncheng Wei. Diabetes mellitus and epithelial ovarian cancer in Chinese women: a retrospective cohort study[J]. European Journal of Gynaecological Oncology, 2020, 41(2): 260-264.
No Suggested Reading articles found!